Pretreatment lactate dehydrogenase may predict outcome of advanced non small‐cell lung cancer patients treated with immune checkpoint inhibitors: A meta‐analysis

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Clinical Efficacy of Immune Checkpoint Inhibitors in Older Non-small-Cell Lung Cancer Patients: A Meta-Analysis

Frontiers in Oncology ◽

10.3389/fonc.2020.558454 ◽

2020 ◽

Vol 10 ◽

Author(s):

You-Meng Sun ◽

Ying Wang ◽

Xin-Xing Sun ◽

Jing Chen ◽

Zhi-Ping Gong ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Sarcopenia affects clinical efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients: A systematic review and meta-analysis

International Immunopharmacology ◽

10.1016/j.intimp.2020.106907 ◽

2020 ◽

Vol 88 ◽

pp. 106907 ◽

Cited By ~ 1

Author(s):

Jiajun Wang ◽

Liu Cao ◽

Shun Xu

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Cancer Patients ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Impact of corticosteroid use on outcomes of non–small‐cell lung cancer patients treated with immune checkpoint inhibitors: A systematic review and meta‐analysis

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.13469 ◽

2021 ◽

Author(s):

Hongchuan Zhang ◽

Xuemei Li ◽

Xingliang Huang ◽

Junfeng Li ◽

Hong Ma ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Cancer Patients ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Prognostic impact of primary cancer adjoining emphysematous bullae in non-small cell lung cancer patients treated with immune checkpoint inhibitors

Cancer Immunology Immunotherapy ◽

10.1007/s00262-020-02783-6 ◽

2021 ◽

Author(s):

Shinkichi Takamori ◽

Kazuki Takada ◽

Mototsugu Shimokawa ◽

Mikako Jinnnouchi ◽

Taichi Matsubara ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Small Cell ◽

Prognostic Impact ◽

Primary Cancer ◽

Small Cell Lung ◽

Blood tumor mutation burden can predict the clinical response to immune checkpoint inhibitors in advanced non-small cell lung cancer patients

Cancer Immunology Immunotherapy ◽

10.1007/s00262-021-02943-2 ◽

2021 ◽

Author(s):

Xi Chen ◽

Liangjie Fang ◽

Yanping Zhu ◽

Zhang Bao ◽

Qing Wang ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Tumor Mutation Burden ◽

Lung Cancer Patients ◽

Mutation Burden

Predictive Value of Combining Biomarkers for Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors

Clinical Lung Cancer ◽

10.1016/j.cllc.2021.03.017 ◽

2021 ◽

Author(s):

Chester Kao ◽

Eric Powers ◽

Yuan Wu ◽

Michael B. Datto ◽

Michelle F. Green ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Immune Checkpoint ◽

Predictive Value ◽

Checkpoint Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Immune Checkpoint Inhibitors Rechallenge Efficacy in Non–Small-Cell Lung Cancer Patients

Clinical Lung Cancer ◽

10.1016/j.cllc.2020.04.013 ◽

2020 ◽

Vol 21 (5) ◽

pp. e497-e510 ◽

Cited By ~ 2

Author(s):

Elisa Gobbini ◽

Anne Claire Toffart ◽

Maurice Pérol ◽

Jean-Baptiste Assié ◽

Michaël Duruisseaux ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Prognostic value of smoking status in non-small-cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis

Oncotarget ◽

10.18632/oncotarget.18703 ◽

2017 ◽

Vol 8 (54) ◽

pp. 93149-93155 ◽

Cited By ~ 28

Author(s):

Jung Han Kim ◽

Hyeong Su Kim ◽

Bum Jun Kim

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Prognostic Value ◽

Checkpoint Inhibitors ◽

Smoking Status ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Does denosumab offer survival benefits? —Our experience with denosumab in metastatic non-small cell lung cancer patients treated with immune-checkpoint inhibitors

Journal of Thoracic Disease ◽

10.21037/jtd-21-150 ◽

2021 ◽

Vol 0 (0) ◽

pp. 0-0

Author(s):

Yenong Cao ◽

Muhammad Zubair Afzal ◽

Keisuke Shirai

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Interstitial lung disease induced by immune-checkpoint inhibitors correlates with prognosis of advanced non-small cell lung cancer patients

Annals of Oncology ◽

10.1093/annonc/mdz260.025 ◽

2019 ◽

Vol 30 ◽

pp. v617 ◽

Cited By ~ 1

Author(s):

T. Sugano ◽

M. Seike ◽

Y. Saito ◽

N. Takano ◽

K. Hisakane ◽

...

Keyword(s):

Lung Cancer ◽

Interstitial Lung Disease ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽